Two visits
An initial clinical assessment and a follow-up review of the findings, with time for a considered discussion.
An in-person evaluation / HoustonMore context.
More context.
A fuller assessment.
A two-visit Comprehensive Consult brings clinical history, relevant laboratory findings and body-composition measurements into one provider-led review.
A considered approach01 02 03
The findings belong together.
40+ biomarker panel
A 40+ biomarker laboratory panel supports the clinical evaluation; findings still require individual interpretation.
Body-composition context
A scan and written plan add context beyond scale weight. Measurements are not promised treatment outcomes.
Clinical assessment
A fuller clinical picture.
The Comprehensive Consult combines two visits, a 40+ biomarker panel, body-composition assessment and a written plan. Testing informs the next decision, not an automatic prescription.
A comprehensive assessment does not guarantee a diagnosis or prescription. Care may involve relevant treatment, further evaluation, referral or no medication.
Discuss at a consultation
The markers. The meaning.
Labs, translated.
A clearer view of the markers that may inform evaluation and follow-up.
AUA diagnostic-support cutoff<300 ng/dL
Total testosterone below this level can support evaluation. It is not a standalone diagnosis or an optimal target. Compatible findings and repeat testing matter.
Clinical marker guideEDUCATION / NO PATIENT VALUES
Total T
Total testosteroneTotal circulating testosterone, including bound and unbound hormone.
Why it matters
Supports evaluation alongside symptoms and repeat morning measurements; one low result is not a diagnosis.
Free T
Free testosteroneUnbound testosterone, measured or calculated with validated methods.
Why it matters
May clarify borderline total testosterone or altered SHBG; not required in every evaluation.
SHBG
Sex hormone-binding globulinProtein that binds testosterone and affects interpretation of total testosterone.
Why it matters
Helps interpret total and calculated free testosterone when binding levels differ.
LH / FSH
Luteinizing hormone / follicle-stimulating hormonePituitary signals involved in testosterone production and sperm development.
Why it matters
When indicated, helps distinguish testicular causes from pituitary or hypothalamic causes.
HbA1c
Hemoglobin A1cAverage blood glucose over approximately two to three months.
Why it matters
Helps assess diabetes risk and monitor glucose management; some blood conditions affect accuracy.
LDL / HDL / TG
Lipid panelCholesterol fractions and triglycerides in blood.
Why it matters
Adds cardiovascular risk context; goals depend on overall risk and clinical history.
DXA
Dual-energy X-ray absorptiometry · body compositionEstimates fat and lean mass; not a blood test.
Why it matters
Shows weight composition beyond the scale; measurement conditions affect comparisons.
IGF-1
Insulin-like growth factor 1 · when indicatedA blood marker reflecting growth-hormone activity, interpreted against age-based ranges.
Why it matters
For suspected growth-hormone disorders or treatment monitoring, not routine wellness screening; a result alone does not diagnose deficiency.
CBC / Hct
Complete blood count / hematocritBlood cell counts and the red-cell proportion of blood.
Why it matters
Testosterone can raise hematocrit; baseline and follow-up testing help assess treatment safety.
PSA
Prostate-specific antigenA prostate-related blood marker; not a cancer diagnosis.
Why it matters
Prostate monitoring depends on age, risk, and shared decision-making; elevated results need clinical interpretation.
Review
Clinical review · not a laboratory testSymptoms, adverse effects, treatment response, and relevant health history.
Why it matters
Connects results with examination, medications, fertility plans, and safety; numbers alone do not determine treatment.
Examples, not a fixed panel. Test selection and timing depend on indication, age, risk, medications, and treatment. Reference ranges vary by assay. DXA and clinical review are not blood tests. AUA guidance ↗
A closer look
Options with context.
A clinical history
Medical history and current medications are considered before interpreting laboratory findings.
An integrated review
Hormone and metabolic findings can be reviewed together while preserving separate diagnostic and treatment decisions.
A written next step
The plan records the clinical discussion and relevant follow-up; it is not a guaranteed treatment protocol.
Costs, stated clearlyA consultation.
A consultation.
A separate care decision.
Self-pay. No insurance billing. HSA/FSA eligibility depends on the individual plan. The clinic confirms the complete cost before care begins.
View all pricingIncludes two visits, a 40+ biomarker panel, body-composition scan and written plan. The $49 targeted video consultation is a different visit; external testing costs are separate.
Book NowBefore a conversation
A few clear answers.
Clinical context matters. These answers explain the process, not an individual recommendation.
Is the comprehensive visit available by video?
The Comprehensive Consult is in person in Houston. The $49 targeted visit may be in person or by video for patients who live in Texas and are located in Texas during the visit.
What happens when findings do not support treatment?
No medication may be recommended. The clinician may discuss further evaluation, another care pathway or referral; booking does not guarantee a prescription.
Separate questions. Connected evaluation.
Patients notice the difference.
“For the first time, I felt really heard about my concerns.”
“I felt truly helped, educated and properly prepared for my future health journey.”
“It’s not one-size-fits-all, it’s catered to you.”
Excerpts from Google reviews. Individual results vary.
Let’s talk
Start with a conversation.
Houston clinic. Texas telehealth.